Lostam BioPharmaceuticals
Treatment for Bacterial Infections
Health Tech & Life Sciences
Non Active, Aug 2016
Company Overview
Snapshot
Founded in October 2009 by Lewis F. Neville, PhD, Lostam BioPharmaceuticals operates with over 8,000 employees. The company is currently in a Pre-Funding stage.
Business overview
Lostam BioPharmaceuticals is a Health Tech & Life Sciences company focused on developing a novel class of protein therapeutics, specifically biologics. These therapeutics are designed to prevent and treat lethal Gram-negative bacterial infections, primarily those associated with hospital settings. The company operates within the Pharma & Medical Biotechnology sector, with a focus on Drugs Discovery & Development and Medical Treatment & Therapeutics.
Company Intelligence Q&A
- What is Lostam BioPharmaceuticals' primary focus?
- Lostam BioPharmaceuticals is primarily focused on developing protein therapeutics to prevent and treat lethal Gram-negative bacterial infections, particularly those acquired in hospital environments.
- When was Lostam BioPharmaceuticals founded?
- Lostam BioPharmaceuticals was founded in October 2009.
- Who is the founder of Lostam BioPharmaceuticals?
- Lewis F. Neville, PhD, is the founder, CEO, and CTO of Lostam BioPharmaceuticals.
- What sector does Lostam BioPharmaceuticals operate in?
- Lostam BioPharmaceuticals operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology.
- What is the current product stage of Lostam BioPharmaceuticals?
- Lostam BioPharmaceuticals' products are currently in the Research & Development (R&D) stage.